InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,970.80
(
-1.23%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.26
(
1.47%
)
Bitcoin
59,241.03
(
-6.20%
)
Post# of 252331
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: pharmaclown35 post# 93962

Thursday, 04/29/2010 9:20:28 AM

Thursday, April 29, 2010 9:20:28 AM

Post# of 252331
Good news for ACOR:

Two projects in Phase II were discontinued. Data on Nerispirdine in improving the ability to walk in multiple sclerosis patients, and on SSR411298 in major depressive disorders, did not support progression to Phase III trials.



http://en.sanofi-aventis.com/binaries/20100429_q1_2010_en_tcm28-28188.pdf
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up